rethinkPeptides Search
Menu
Study breakdown

Hypothalamic Vasopressin Pain Relief Uses Spinal Opioid Peptides as Downstream Mediators

evidence
The takeaway

Analgesia from hypothalamic paraventricular nucleus vasopressin involved endogenous opioid peptide release in the spinal cord, establishing a hypothalamic-spinal vasopressin-opioid pain control axis.

Key finding

Analgesia from hypothalamic paraventricular nucleus vasopressin involved endogenous opioid peptide release in the spinal cord, establishing a hypothal

What the researchers found

Analgesia from hypothalamic paraventricular nucleus vasopressin involved endogenous opioid peptide release in the spinal cord, establishing a hypothalamic-spinal vasopressin-opioid pain control axis.

Why it matters

Relevant for peptide research.

How the study worked

research study.

What this study cannot tell us

See abstract.

How to read the evidence

emerging evidence.

When this study was published

Published in 2009.

The bigger picture

Advances peptide research.

Questions still open

  • Further research needed.

Common questions

What was studied?
Hypothalamic Vasopressin Pain Relief Uses Spinal Opioid Peptides as Downstream Mediators
What was found?
Analgesia from hypothalamic paraventricular nucleus vasopressin involved endogenous opioid peptide release in the spinal cord, establishing a hypothalamic-spinal vasopressin-opioid pain control axis.

Read the original research

Endogenous opiate peptides in the spinal cord are involved in the analgesia of hypothalamic paraventricular nucleus in the rat.

Peptides, 30(4), 740-4

Citation

Yang, Jun; Yang, Yu; Chu, Jiegen; Wang, Gen; Xu, Hongtao; Liu, Wen-Yan; Wang, Cheng-Hai; Lin, Bao-Cheng. (2009). Endogenous opiate peptides in the spinal cord are involved in the analgesia of hypothalamic paraventricular nucleus in the rat.. Peptides, 30(4), 740-4.